- Home
- PROV vs HOWL Comparison
PROV vs HOWL Comparison
Compare PROV & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROV
- HOWL
- Stock Information
- Founded
- PROV 1956
- HOWL 2017
- Country
- PROV United States
- HOWL United States
- Employees
- PROV N/A
- HOWL N/A
- Industry
- PROV Savings Institutions
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- PROV Finance
- HOWL Health Care
- Exchange
- PROV Nasdaq
- HOWL Nasdaq
- Market Cap
- PROV 109.1M
- HOWL 87.4M
- IPO Year
- PROV 1996
- HOWL 2021
- Fundamental
- Price
- PROV $15.91
- HOWL $1.55
- Analyst Decision
- PROV Hold
- HOWL Strong Buy
- Analyst Count
- PROV 1
- HOWL 2
- Target Price
- PROV $16.00
- HOWL $13.50
- AVG Volume (30 Days)
- PROV 8.3K
- HOWL 344.3K
- Earning Date
- PROV 01-27-2025
- HOWL 11-07-2024
- Dividend Yield
- PROV 3.52%
- HOWL N/A
- EPS Growth
- PROV N/A
- HOWL N/A
- EPS
- PROV 1.09
- HOWL N/A
- Revenue
- PROV $39,794,000.00
- HOWL $3,386,000.00
- Revenue This Year
- PROV N/A
- HOWL N/A
- Revenue Next Year
- PROV $11.75
- HOWL $34.17
- P/E Ratio
- PROV $14.66
- HOWL N/A
- Revenue Growth
- PROV N/A
- HOWL N/A
- 52 Week Low
- PROV $12.01
- HOWL $1.38
- 52 Week High
- PROV $16.70
- HOWL $8.19
- Technical
- Relative Strength Index (RSI)
- PROV 44.41
- HOWL 36.96
- Support Level
- PROV $16.30
- HOWL $1.50
- Resistance Level
- PROV $16.37
- HOWL $1.63
- Average True Range (ATR)
- PROV 0.24
- HOWL 0.12
- MACD
- PROV -0.07
- HOWL 0.00
- Stochastic Oscillator
- PROV 21.00
- HOWL 30.09
About PROV Provident Financial Holdings Inc.
Provident Financial Holdings Inc is a holding company of Provident Savings Bank, F.S.B. Through the bank, it is engaged in providing community and mortgage banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's business segment is Bank. The Bank's activities include attracting deposits, offering banking services, and originating and purchasing single-family, multi-family, commercial real estate, construction, and other mortgage loans and, to a lesser extent, commercial business and consumer loans held for investment.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.